Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8474
|
pubmed:dateCreated |
1986-3-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
214-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2868239-Animals,
pubmed-meshheading:2868239-Antibody Formation,
pubmed-meshheading:2868239-Bacterial Vaccines,
pubmed-meshheading:2868239-Humans,
pubmed-meshheading:2868239-Meningitis, Meningococcal,
pubmed-meshheading:2868239-Mice,
pubmed-meshheading:2868239-Neisseria meningitidis,
pubmed-meshheading:2868239-Polysaccharides, Bacterial
|
pubmed:year |
1986
|
pubmed:articleTitle |
Vaccine against meningococcal group B disease.
|
pubmed:publicationType |
Letter
|